Reading between the lines regarding the comments on lithium there, it almost reads to me as though he was saying that our lithium tenements are small and not necessarily worth exploring at the moment, in this climate. It may not be worth our time so it might be easier to farm it out to another company hoping for some return at least.
If that's the case then that exploration target stated by the company at Cancet is highly suspect. The very high grade mineralisation there starts at surface, which in mining terminology means that this is the most viable type of deposit for building a mine and extracting it. In laymans terms it means that for every $10 spent on mine development, extraction and processing, a minimum profit of $30 should be returned. Or so I believe.
So if it's not worth exploring, how off is that exploration target?
And if that exploration target has been updated, can the market please be informed via an announcement to the ASX.
- Forums
- ASX - By Stock
- MTC
- MTC Shareholder Activists
MTC
metalstech limited
Add to My Watchlist
3.85%
!
13.5¢

MTC Shareholder Activists, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $28.17M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $3.713K | 27.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 0.130 |
4 | 44619 | 0.125 |
3 | 138341 | 0.120 |
1 | 10000 | 0.100 |
1 | 10500 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 1000 | 1 |
0.140 | 22528 | 3 |
0.145 | 126965 | 4 |
0.150 | 50000 | 1 |
0.155 | 35745 | 1 |
Last trade - 14.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MTC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online